Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Big Pharma Deal
View:
Post by BradlTheGerman on Feb 22, 2022 5:46am

Big Pharma Deal

If there is a big deal in the near future, than the stock will be halted.
 
This will cause hopefully a lot of smiling faces. Including me.
 
I am convinced that a deal will happen sooner or later, but the numbers of this deal are mainly importent. 

A good news can hit us at any time now. Always think positive.
Comment by MirrorWorldMan on Feb 22, 2022 12:23pm
There needs to be numbers, any numbers, for investors to assess the value of deals. When Howie provides his useless updates at the very least he needs to provide sales numbers from R+F for example. Scheduled earnings calls every Qtr, with Q & A, like other legitimate companies is necessary to apper remotely legitimate. Or is our part time CEO too busy on his full time job?  Being a CEO ...more  
Comment by biorun on Feb 22, 2022 12:28pm
You do know this is an R&D company you invested in. Licensing royalties revenues, upfront payments, and buyout potential. This is not a blue chip, nor is it a company with quarters earnings calls like Pfizer or Johnson and Johnson. These are their potential customers. Enough with the BS and whining please. Make a contribution.
Comment by navajojoe on Feb 22, 2022 1:32pm
This post has been removed in accordance with Community Policy
Comment by biorun on Feb 22, 2022 1:39pm
I love you too.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities